APOE ε4与认知障碍参与者的突触密度下降有关
概括
阿波利波蛋白E4 (APOE) ε4基因基因与认知障碍患者的突触密度降低有关. 这种突触损失可能受到阿尔茨海默氏症的影响.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 放射学 放射学是一门学科.
背景情况:
- 阿波利波蛋白E (APOE) ε4等位基因是阿尔茨海默病 (AD) 的重要遗传风险因素.
- 突触功能障碍是AD病变发生的早期事件.
- 了解APOE ε4与突触完整性之间的关系对于早期诊断和治疗至关重要.
研究的目的:
- 研究APOE ε4等位基对认知障碍 (CI) 参与者的突触密度的影响.
- 探索AD生物标志物如何调解APOE ε4和突触密度之间的关联.
主要方法:
- 110名CI参与者接受了粉样蛋白PET (F-florbetapir) 和突触密度PET (F-SynVesT-1) 扫描.
- 分析APOE ε4等位基因对中间叶突触密度的影响.
- 对AD生物标志物 (粉样β和tau) 的调解分析,以 ε4相关的突触密度变化.
主要成果:
- 与非载体相比,APOE ε4载体在叶中部的突触密度明显较低.
- 粉样β和tau病理部分介导了APOE ε4对突触密度的影响.
- 突触密度和tau病理之间的关系是由APOE ε4基因型调节的.
结论:
- APOE ε4等位基因与CI个体的突触密度降低有关.
- 阿尔茨海默病的生物标志物,包括粉样蛋白和病理,似乎驱动着与APOE ε4相关的突触损失.
相关概念视频
Alzheimer's Disease: Overview
475
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
475
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K


